Versor Investments LP Invests $337,000 in Sotera Health (NASDAQ:SHC)

Versor Investments LP acquired a new position in Sotera Health (NASDAQ:SHC) in the 3rd quarter, Holdings Channel reports. The institutional investor acquired 20,200 shares of the company’s stock, valued at approximately $337,000.

A number of other hedge funds also recently bought and sold shares of SHC. Wedmont Private Capital raised its position in Sotera Health by 6.5% in the third quarter. Wedmont Private Capital now owns 10,915 shares of the company’s stock worth $169,000 after acquiring an additional 664 shares during the period. First Citizens Bank & Trust Co. increased its stake in shares of Sotera Health by 5.0% in the 3rd quarter. First Citizens Bank & Trust Co. now owns 14,287 shares of the company’s stock worth $239,000 after purchasing an additional 677 shares in the last quarter. CWM LLC raised its holdings in Sotera Health by 86.1% in the 2nd quarter. CWM LLC now owns 2,146 shares of the company’s stock worth $25,000 after purchasing an additional 993 shares during the period. Swiss National Bank lifted its position in Sotera Health by 0.5% during the first quarter. Swiss National Bank now owns 195,900 shares of the company’s stock valued at $2,353,000 after purchasing an additional 1,000 shares in the last quarter. Finally, GAMMA Investing LLC grew its holdings in Sotera Health by 125.0% during the third quarter. GAMMA Investing LLC now owns 2,988 shares of the company’s stock valued at $50,000 after purchasing an additional 1,660 shares during the period. Hedge funds and other institutional investors own 91.03% of the company’s stock.

Insider Buying and Selling at Sotera Health

In other news, Director Gtcr Investment Xi Llc sold 10,000,000 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $15.03, for a total transaction of $150,300,000.00. Following the completion of the transaction, the director now directly owns 49,215,301 shares in the company, valued at approximately $739,705,974.03. This represents a 16.89 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 55.12% of the stock is currently owned by insiders.

Sotera Health Stock Down 4.5 %

Shares of SHC opened at $14.31 on Friday. The business’s 50 day moving average is $15.96 and its 200 day moving average is $13.85. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 12-month low of $10.71 and a 12-month high of $17.44. The company has a market capitalization of $4.05 billion, a PE ratio of 58.00 and a beta of 2.08.

Sotera Health (NASDAQ:SHC) last released its quarterly earnings data on Tuesday, November 5th. The company reported $0.17 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.18 by ($0.01). Sotera Health had a net margin of 6.31% and a return on equity of 42.27%. The company had revenue of $285.47 million for the quarter, compared to the consensus estimate of $278.64 million. During the same quarter in the previous year, the business earned $0.18 EPS. The company’s quarterly revenue was up 8.5% on a year-over-year basis. Research analysts expect that Sotera Health will post 0.61 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms have recently commented on SHC. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $17.00 price objective on shares of Sotera Health in a research note on Tuesday, August 6th. Barclays raised their target price on shares of Sotera Health from $14.00 to $17.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 6th. Finally, Citigroup upped their price target on shares of Sotera Health from $18.00 to $20.00 and gave the stock a “buy” rating in a research report on Wednesday, November 6th. Two analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $16.50.

About Sotera Health

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.